Conversion from calcineurin inhibitors to sirolimus in chronic allograft nephropathy: benefits and risks

Nephrol Dial Transplant. 2006 Mar;21(3):562-8. doi: 10.1093/ndt/gfi336. Epub 2005 Dec 16.
No abstract available

Publication types

  • Comment
  • Editorial
  • Review

MeSH terms

  • Calcineurin Inhibitors*
  • Chronic Disease
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Kidney Transplantation*
  • Postoperative Complications
  • Proteinuria / drug therapy*
  • Proteinuria / metabolism
  • Sirolimus / therapeutic use*
  • Treatment Outcome

Substances

  • Calcineurin Inhibitors
  • Immunosuppressive Agents
  • Sirolimus